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Abstract
Background: Bovine coronavirus (BCoV) is a widely distributed pathogen, causing disease and economic losses in
the cattle industry worldwide. Prevention of virus spread is impeded by a lack of basic knowledge concerning viral
shedding and transmission potential in individual animals. The aims of the study were to investigate the duration
and quantity of BCoV shedding in feces and nasal secretions related to clinical signs, the presence of virus in blood
and tissues and to test the hypothesis that seropositive calves are not infectious to naïve in-contact calves three
weeks after BCoV infection.
Methods: A live animal experiment was conducted, with direct contact between animal groups for 24 h as challenge
procedure. Four naïve calves were commingled with a group of six naturally infected calves and sequentially
euthanized. Two naïve sentinel calves were commingled with the experimentally exposed group three weeks after
exposure. Nasal swabs, feces, blood and tissue samples were analyzed for viral RNA by RT-qPCR, and virus isolation was
performed on nasal swabs. Serum was analyzed for BCoV antibodies.
Results: The calves showed mild general signs, and the most prominent signs were from the respiratory system. The
overall clinical score corresponded well with the shedding of viral RNA the first three weeks after challenge. General
depression and cough were the signs that correlated best with shedding of BCoV RNA, while peak respiratory rate and
peak rectal temperature appeared more than a week later than the peak shedding. Nasal shedding preceded fecal
shedding, and the calves had detectable amounts of viral RNA intermittently in feces through day 35 and in nasal
secretions through day 28, however virus isolation was unsuccessful from day six and day 18 from the two calves
investigated. Viral RNA was not detected in blood, but was found in lymphatic tissue through day 42 after challenge.
Although the calves were shedding BCoV RNA 21 days after infection the sentinel animals were not infected.
Conclusions: Prolonged shedding of BCoV RNA can occur, but detection of viral RNA does not necessarily indicate a
transmission potential. The study provides valuable information with regard to producing scientifically based
biosecurity advices.
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Background
Bovine coronavirus (BCoV) is an important livestock
pathogen with a high prevalence worldwide. The virus
causes respiratory disease and diarrhea in calves and
winter dysentery in adult cattle. These diseases result in
substantial economic losses and reduced animal welfare
[1]. One way of reducing the negative consequences of
this virus is to prevent virus transmission between herds.
Inter-herd transmission is possible either directly via
transfer of live animals [2, 3], or indirectly via contami-
nated personnel or equipment [4]. Measures to prevent
virus spread between herds must be based upon know-
ledge of viral shedding, the potential for transmission to
susceptible animals and the role of protective immunity.
Several observational studies have been published on
BCoV shedding in feces of diarrheic calves and after
transportation to feedlots [3, 5–10]. However, relatively
few studies on BCoV pathogenesis with emphasis on
transmission potential under controlled conditions have
been published.
BCoV belongs to the genus Betacoronavirus within the
family Coronaviridae, also including the closely related
HCoV-OC43, which causes respiratory infections in
humans, and the human pathogens SARS-CoV and
MERS-CoV [11–13].
BCoV consists of one serotype with some antigenic vari-
ation between different strains [14, 15]. Acutely infected
animals develop antibodies that persist for a long period,
possibly for several years [16–18]. However, the protective
immunity is shorter and incomplete. In two experimental
studies, infected calves were not protected against reinfec-
tion with a different BCoV strain three weeks after the first
challenge, but did not develop clinical signs [19, 20].
BCoV is transmitted via the fecal-oral or respiratory
route [15]. It infects epithelial cells in the respiratory
tract and the intestines; the nasal turbinates, trachea and
lungs and the villi and crypts of the small and large in-
testine, respectively [21, 22]. Replication leads to shed-
ding of virus in nasal secretions and in feces. Important
factors for the pathogenesis are still not fully explored,
such as how the virus infects enterocytes shortly after
introduction to an animal. Viremia has been detected in
one study by Park et al. [21]. Clinical signs range from
none to severe, and include fever, respiratory signs and
diarrhea with or without blood [1, 15]. As the time of in-
fection is usually unknown and laboratory diagnostics
are usually not performed, occurrence of clinical signs is
the most relevant parameter to relate to viral shedding.
The majority of experimental studies have used BCoV
inoculation as challenge procedure, which may influence
clinical signs and viral shedding, and thereby the transmis-
sion potential compared to natural infection. It has been
hypothesized that BCoV can cause chronic subclinical in-
fections which could be an important virus source [15].
Kapil et al. documented viral antigen in the small and
large intestines of infected calves three weeks post inocu-
lation [23]. Crouch et al. found that ten cows were shed-
ding BCoV-immune complexes in the feces for 12 weeks
[24]. It is, however, difficult to establish whether there is
true persistence of virus, or reinfection of partially im-
mune animals and whether these animals represent a risk
to other animals. There is a lack of experimental studies
investigating viral shedding pattern for longer periods
than two weeks, with sensitive detection methods. Viral
load and infectivity also needs to be determined. This is of
high practical relevance, since the farmers need guidance
on biosecurity in trade and transport of live animals.
The current study was conducted to fill prevailing gaps
in the knowledge on fundamental aspects of BCoV in-
fection. The specific aims were to:
1. study the duration and quantity of BCoV shedding
in feces and nasal secretions, related to clinical signs
in calves.
2. study the presence of viremia and persistence of
virus in lymphatic, intestinal and lung tissue.
3. test the hypothesis that seropositive calves are not




A live animal experiment with the natural host was con-
ducted. The experimental units were groups of calves
and the intervention consisted of direct contact with
BCoV-infected animals. The primary outcome was clin-
ical signs, and the secondary outcome was presence of
BCoV RNA and BCoV antibodies. Three experimental
groups were included; the Field group (FG, n = 6) that
was naturally infected with BCoV, the naïve Exposed
group (EG, n = 4) and the naïve Sentinel group (SG, n = 2).
An overview of the study design is shown in Fig. 1.
Animals, housing and husbandry
Animals
Twelve BCoV seronegative weaned bull calves between
six and twelve weeks of age were included, seven were
Swedish red and white, four were Swedish Holstein and
one Swedish mountain breed. They originated from two
dairy herds, initially negative for antibodies to BCoV in
milk from primiparous cows. The calves were allocated
to groups according to herd of origin and day of arrival.
The sequence of euthanasia of the EG and SG calves
was random, determined by drawing of lots.
Natural outbreak of winter dysentery
FG originated from a herd that was in an early phase of
a winter dysentery outbreak. When FG was transported
Oma et al. Virology Journal  (2016) 13:100 Page 2 of 11
to the research facility, the calves showed mild signs of
respiratory disease. Two days later, a severe outbreak
confirmed by RT-PCR and serology to be caused by
BCoV with bloody diarrhea and reduction in milk pro-
duction, took place in the herd.
Research facility
The experiment was conducted at the stationary clinic at
the Department of Clinical Sciences at the Swedish Uni-
versity of Agricultural Sciences. The facility was closed
for other animals during the experiment, and had re-
stricted admission for people. Personnel used designated
clothing, and had no contact with other cattle the same
day. Each group was housed in separate pens within the
same room. Due to the type of facility and design of the
study, acclimatization period was not possible for any of
the groups. Clinical examinations and sampling were
consistently done in the order SG, EG and FG.
Challenge procedure
To mimic standard managerial conditions, direct contact
was chosen as challenge procedure for both EG and SG.
The commingling was done by moving EG into the
other two groups’ pens for 24 h.
Refinement and treatment procedures
Efforts were made to minimize the stress and discomfort
for the animals involved. The calves were kept group-
wise in pens with straw bedding, were fed a commercial
calf concentrate twice daily and had access to haylage ad
libitum. The animals were monitored by a trained ani-
mal technician and a veterinarian at least three times a
day. Indications for antibiotic treatment (30 000 IU
procaine benzyl penicillin/kg bodyweight/day i.m. for
five consecutive days) were abnormal sounds on lung
auscultation or prolonged high temperature. Indication
for treatment with a non-steroidal anti-inflammatory
drug (Metacam vet, Boehringer Ingelheim Vetmedica,
Germany) was severe depression, and oral fluid with
electrolytes was to be given to moderately dehydrated
animals. Euthanasia was achieved by i.v. injection of
pentobarbital (Euthasol vet., Le Vet, Netherlands).
Clinical score
Daily clinical examinations were performed by a veterin-
arian and clinical signs were scored as presented in
Table 1 (modified after Hägglund et al. [25, 26] and
Silverlås et al. [27]). A score above two on three con-











Fig. 1 Timeline of the experiment. The solid lines symbolize the timespan when the calves participated in the experiment. The dashed lines
symbolize commingling of the indicated animals for 24 h; e.g. the field group arrived at the research facility on day −7, commingled with the
exposed group day 0 and left the research facility day 14. The calves in the exposed group were sequentially euthanized from day 22 to day 42.
The Sentinel group arrived at the research facility day 21 and commingled with the Exposed group the following 24 hours
Table 1 Clinical scoring system
Score Respiratory rate
(breaths/min)
Fever Cough Nasal discharge Demeanor Fecal consistency
0 ≤49 ≤39,5 No cough observed Normal Bright, alert Normal
1 50–54 39,6–39,9 Sporadic cough Serous or mucous Mildly depressed Pasty
2 55–64 40–40,4 More than one sporadic cough
every 10 min of observation
Mucopurulent or purulent Moderately depressed Runny
3 65–74 >40,5 – – Severely depressed Watery
4 75–85 – – – – Runny or watery with blood
The score from each category was added to give a daily clinical score for each of the calves in the experiment
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score above six on three consecutive days as moderate
disease and a score above eleven was categorized as se-
vere clinical disease.
Collection of material
Nasal swab specimens and fecal samples from FG were
collected approximately every third day from day −4 (D-4)
to D14. From EG, nasal swabs and fecal samples were col-
lected every day from D0 to D25 and then every third day
until D35. Nasal swabs from SG were collected D24, D27
and D29. The nasal specimens were collected by rotating
a flocked ESwab™ (Copan, Brescia, Italy) approximately
five cm inside one of the calf ’s nostrils. The specimens
were frozen and stored at −70 °C before further process-
ing. Blood was drawn from the jugular vein upon arrival
and D1, D2, D3, D5, D7, D9, D11, D14, D21, D35 and
D41 using sterile evacuated tubes with and without
EDTA-anticoagulant. The EDTA-blood was centrifuged
and the cell fractions were stored separately at −80 °C be-
fore further processing. Sera were stored at −20 °C until
analyzed. Tissue samples from lung, medial retropharyn-
geal and mesenteric lymph nodes, ileum, and colon were
stored in RNA-later at −20 °C.
Antibody ELISA
Serum samples were analyzed for anti BCoV IgG by
Svanovir BCV-Ab (Boehringer Ingelheim Svanova, Uppsala,
Sweden) according to the manufacturer’s instructions.
Samples from SG were also tested for antibodies to bovine
respiratory syncytial virus (BRSV) by Svanovir BRSV-Ab
(Boehringer Ingelheim). The optical density (OD) at
450 nm was measured and corrected by subtracting the
OD for the negative control. Percent positivity (PP) was
calculated as (sample OD/positive control OD) × 100, and
a PP-value of <10 was regarded as negative.
Extraction of RNA and RT-qPCR
Fecal samples (diluted 1:10 in PBS) and nasal swab spec-
imens were centrifuged at 9700 x g for 10 min. RNA was
extracted from 140 μl supernatant and 140 μl plasma by
QIAamp Viral RNA Mini QIAcube kit (Qiagen, Hilden,
Germany), eluted in 50 μl and frozen at −80 °C. RNA
from blood cell fractions from calf E4 on D5 and calf E3
on D7 was extracted with Qiazol (Qiagen) and chloro-
form phase separation mixed with 70 % ethanol (1:1)
and purified using RNeasy Mini Kit column (Qiagen),
while RNA was extracted from 30–50 mg tissue samples,
using RNeasy Plus Universal Mini Kit (Qiagen). RT-
qPCR was performed using RNA UltraSense™ One-Step
Quantitative RT-PCR System (Invitrogen, MA, USA).
Two microliters of RNA was added to a 18 μl reaction
volume containing 200 nM each of forward and reverse
primers and 250 nM TaqMan probe [28]. The thermal
profile included an RT step with 30 min at 55 °C
followed by 95 °C for 2 min. Thereafter, 40 cycles with
15 s at 95 °C and 60 s at 60 °C were conducted. The
RT-qPCR was performed on a Stratagene Mx3005p™
(Agilent Technologies, CA, USA) and a positive and a
negative control were included in each run. In order to
evaluate inhibition of the RT-qPCR, RNA extract from
some fecal samples were diluted 1:10 and compared to
undiluted RNA. The Ct-values in these samples suggested
negligible levels of inhibitors. Inhibitors in plasma and cell
extracts were evaluated by spiking with mengovirus RNA.
Comparison of Ct-values showed that plasma had no
negative effect, while the cell fractions had an inhibitory
effect, giving an increase of one Ct-value.
Virus quantitation
In order to estimate the number of BCoV viral RNA
copies (VRC) in the clinical samples, a standard curve
was prepared using tenfold dilutions of a plasmid con-
taining the BCoV target sequence. Aliquoted BCoV
RNA was used as a calibrator and included in every RT-
qPCR plate to adjust for inter plate variation. The num-
ber of VRC in the clinical samples was calculated using
the formula:
QS ¼ QC  10
CtS−CtC
m
Where Qs = viral RNA copies in sample, Qc = viral RNA
copies of calibrator, Cts = Ct value of sample, Ctc = Ct
value of calibrator and m= slope of the standard curve.
The standard curve covered the range from 10.8 to
1.08 × 1010 plasmid copies, and showed a strong linear
relationship with a high coefficient of determination
(R2 = 0.996) and a high amplification efficiency (96.5 %).
The limit of quantification (LOQ) for the plasmid was
10.8 copies which represented 3.6 log10 BCoV VRC per
nasal swab and ml plasma, 4.6 log10 VRC/g feces and 4.2
log10 VRC/g tissue.
Virus isolation
Virus infectivity was tested by virus isolation from nasal
swabs from E1 and E3 between D3 and D28 (D3, D6,
D7, D8, D10, D13, D18, D23 and D28). The swab super-
natants were diluted 1:25 in Dulbecco’s Modified Eagle
Medium (DMEM, Thermo Fisher Scientific, Paisley,
Scotland), filtered through a 0.8 μm filter (Sartorius
Stedim Biotech, Goettingen, Germany) and added to a
monolayer of 4-days-old human rectal tumor cells
(HRT-18G, ATTCC CRL-11663) in a 24-well plate. In
addition, infective virus was titrated from one nasal swab
supernatant using two-fold endpoint dilutions in a 96-
well plate. After 1 h incubation at 37 °C, the inoculum
was replaced with DMEM with 1 % fetal calf serum and
antibiotics (5000 IU penicillin and 5 mg streptocillin/
ml). After two days at 37 °C and 5 % CO2, the cells were
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fixed with Intracellular Fixation buffer (eBiosience, CA,
USA) and stained with 1:80 dilution of monoclonal mouse
anti-coronavirus antibody labelled with fluorescein iso-
thiocynate (BioX Diagnostics, Rochefort, Belgium) and
DAPI nuclear counterstain (Thermo Fischer Scientific).
The wells were observed under a fluorescent microscope
for antigen positive cells.
Results
Clinical outcome
An overview of clinical signs in all groups is presented in
Table 2. Five out of six FG calves showed mild clinical dis-
ease. EG’s daily clinical scores are shown in Fig. 2. Three
out of four EG calves showed mild disease, and one calf
moderate clinical disease. SG did not develop clinical signs
that were categorized as disease in the clinical scoring sys-
tem. However, both calves had some days with intermit-
tent nasal discharge and sporadic cough and S1 had a few
days with intermittently runny feces. Blood-tinged diarrhea
or nasal discharge was not observed in any of the groups.
Serology
All calves tested negative for antibodies to BCoV at the
beginning of the trial. At D14 all calves in FG and EG
had seroconverted (Additional file 1: Table S1). The SG
was still seronegative to BCoV D42 and did not show an
increase in titer for antibodies to BRSV.
Viral RNA in blood
BCoV RNA was not detected in any of the blood sam-
ples analyzed.
Nasal shedding of viral RNA
The nasal shedding of BCoV RNA from FG and EG is
presented in Fig. 3a, and Fig. 2 shows EG calves’ individ-
ual shedding. Briefly, FG was shedding BCoV RNA D-4
through D11, and in EG all swabs were positive from D1
through D12, and at least one out of four calves was
positive through D28 (Fig. 3a). Two calves were positive
in nasal swabs with a concentration of 5.4 log10 and 4.0
log10 VRC/swab the day of commingling with SG. None
of the nasal swabs from SG were positive.
Fecal shedding of viral RNA
Fecal shedding of BCoV RNA in FG and EG is shown in
Fig. 3b, and the individual shedding from EG in Fig. 2.
Viral RNA was detected in fecal samples from FG be-
tween D-4 and D14. Fecal samples from EG were nega-
tive D0 and D1. At least two out of four calves were
positive every day from D2 through D17 and BCoV
RNA was intermittently detected through D35. After
D14, three calves had a period of four to six days with
negative results, before they again started shedding
BCoV RNA for three to five days (Fig. 2).
Association between PCR positivity and clinical signs
The association between BCoV PCR results and selected
clinical signs is shown in Figs. 4 and 5. The overall clin-
ical score showed good correlation with detection of
BCoV RNA. General depression and cough were the in-
dividual scores that showed the best association with
BCoV RNA shedding. The highest mean respiratory rate
and rectal temperature appeared more than a week later
than the peak shedding.



















Field F1 40,3 0 3 1 0 5 0 −1
F2 39,8 3 2 1 0 8 2 3
F3 40,1 2 0 7 0 7 1 −5e
F4 40,6 1 0 4 1 7 2 2
F5 39,7 2 13 1 2 6 0 -
F6 39,2 1 0 4 0 5 0 -
Exposed E1 39,5 7 0 2 3 7 1 -
E2 39,8 4 1 7 1 8 3 7
E3 40,2 8 1 19 2 9 5 5 and 18
E4 39,9 6 1 8 0 8 4 -
Sentinel S1 39,2 1 4 3 0 5 0 -
S2 39,4 2 0 3 0 4 0 -
The calves were exposed to BCoV in the field (F1-6), were exposed to F-animals (E1-4) or exposed to E-animals (S1-2). aPeak rectal temperature (rt) bRunny to
watery stools were considered diarrheic. c Mucopurulent or purulent nasal discharge (nasal discharge score =2). d Five days of i.m. treatment with 30 000 IU
procaine benzylpenicillin was initiated on indicated day. e Calf F3 was treated for six days
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Viral RNA in tissues
Viral RNA was detected in lymph nodes from the EG
calves euthanized three, four, five and six weeks after in-
fection (Table 3). Viral RNA was also detected in ileum
and colon from the animals euthanized five and six
weeks after infection, but not in lung tissue.
Virus isolation
Virus was isolated from nasal swabs from calf E1 on D3
and from E3 in the period D3 to D13. A photograph of
infected cells is shown in Fig. 6. The titer of infective
BCoV in the nasal swab was 2560 per 50 μl swab
medium (1 ml in total) corresponding to 4.7 log10 infect-
ive particles in a swab containing 9.8 log10 VRC, giving a
total to infective particles ratio (T/I) of 5 log10.
Discussion
The present study showed that calves infected with
BCoV shed viral RNA for five weeks, and harbored viral
RNA in intestinal tissues and lymph nodes even longer.
Interestingly, contact with these calves three weeks after
challenge, when the clinical condition had improved and
the calves had seroconverted, did not lead to infection in
sentinel calves and virus isolation was not possible from
calves shedding viral RNA at this time point.
In concordance with other studies [18, 29], all EG calves
became BCoV positive shortly after contact with infected
calves and shed viral RNA continuously for two weeks. This
supports that introduction of BCoV into a naïve population
leads to a high basic reproduction number (R0). R0 depends
on the duration of the infectious period, the number of
exposed susceptible individuals and the probability of a
susceptible individual to be infected. In herds and transpor-
tation systems where cattle from different herds are com-
mingled, the risk of virus transmission is high.
The detection of BCoV RNA in nasal swabs from
naïve calves in EG shortly after exposure might be due
to passive inhalation of virus excreted by the FG, or to
virus replication in the respiratory tract. Since the viral
load in the nasal swabs from EG exceeded that of FG at
D2, the study confirms that BCoV replicated massively



































































































Days after commingling with infected calves
Calf E4
log10 viral RNA copies/nasal swab




0 2 4 6 8 10 12 14 16 18 20 22 24 26 28
Fig. 2 Clinical score and viral shedding in BCoV infected calves. Number of BCoV viral RNA copies (VRC) per nasal swab and per gram of feces
collected from calves in the Exposed group (EG) from day 0 (the day of commingling with the Field group) through day 35. Limit of quantification
(LOQ) in nasal swab specimens and fecal samples is indicated with horizontal lines. The values under LOQ are extrapolated and less accurate. A star
indicates the day of seroconversion (percent positivity > 10) to BCoV and the arrow indicates the day of commingling with the Sentinel group (day
21). The clinical scores are calculated based on daily registrations of clinical signs from the calves in EG
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started later than nasal shedding which is in concurrence
with other studies [30]. Saif and colleagues found that
when inoculating calves intranasally, BCoV was first de-
tected in nasal epithelial cells and secondly in feces. In
contrast, in calves inoculated orally, fecal detection of
BCoV preceded detection in nasal swab specimens. They
concluded that the infection route could determine the se-
quence of infection of the respiratory and intestinal tract
[22]. The present study supports that the respiratory route
is the most common infection route when calves are
naturally infected by direct contact. With indirect virus
spread, the fecal-oral route could be more common.
Nasal swabs were more often positive for BCoV than
fecal samples in this trial, most likely due to a higher
limit of detection for BCoV in feces than in nasal swabs.
For diagnostic purposes, nasal swab specimens therefore
seem advantageous to fecal samples for virus detection
in calves with suspected BCoV related disease.
Moving and commingling are associated with stress,
which has been found to affect the intestinal immune
system [31]. It is possible that stress increased the BCoV
RNA shedding observed in the EG calves after introduc-
tion of the sentinel calves. Buying and selling of calves
often involve extended transportation and commingling
with susceptible cattle. The stress response, and a pos-
sible increased fecal shedding of virus, would probably

















































































Mean log10 VRC/g feces Mean log10 VRC/nasal swab Mean clinical score
Fig. 4 Clinical score and viral shedding in calves exposed to BCoV. Mean clinical score and mean log10 viral RNA copies (VRC) of BCoV per nasal















































Fig. 3 Log10 viral RNA copies (VRC) of BCoV per nasal swab (a) and
gram feces (b). Shedding of BCoV from calves in the Field group (FG)
(dark grey) and in the Exposed group (EG) (light grey). Grey arrow; day of
EG and FG commingling. Black arrow; day of Sentinel group and EG
commingling. The horizontal lines show the limit of quantification of VRC
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In the acute stage of the infection, the agreement be-
tween positive PCR results and clinical score was relatively
high. Three weeks after exposure to BCoV, the clinical
signs and detection of viral RNA varied more independ-
ently. In an experiment with porcine deltacoronavirus, the










































































































































































Mean log VRC/g feces Mean log VRC/nasal swab Mean rectal temperature score
Fig. 5 Association between viral shedding and scoring of clinical signs. Mean daily shedding of BCoV and scoring of demeanor (a), fecal consistency
(b), respiratory rate (c) and rectal temperature (d) of calves in the Exposed group after exposure to BCoV infected calves. The shedding is shown as
mean log10 viral RNA copies (VRC) of BCoV per nasal swab and gram feces
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shedding of virus in conventionally reared piglets, only in
gnotobiotic piglets [32]. This indicates that secondary
pathogens and changes in microbiota are important for
disease development and clinical signs. The present study
supports that after the acute stage of disease other factors
than virus replication are important for clinical signs; for
instance secondary bacterial infections.
Although the sentinel calves did not get infected with
BCoV, they showed sporadic unspecific signs during the
trial, but below the mildest category “mild disease” in
the clinical scoring system. Since acclimatization was
not possible, the calves changed environment including
feeding routines when enrolled in the experiment, which
could cause the signs observed. Other infectious agents
could also have been present, and if so, most likely less
virulent pathogens. Bovine virus diarrhea virus and bo-
vine herpesvirus 1 are not present in Sweden [33], and
the sentinel calves showed no serologic response to
BRSV. Co-infection between BCoV and other agents is
likewise possible in FG and EG, as is the case under field
conditions.
Unlike most enteric viruses, BCoV is enveloped and
therefore susceptible to environmental inactivation [1].
One might expect that the conditions in the forestom-
aches and abomasum would inactivate BCoV and one
possibility is that BCoV is transported from the oronasal
cavity to the small intestines through the bloodstream.
However, viremia was not detected in the present study,
and transport of the virus to the intestines appears to
have been through the digestive tract. Park and col-
leagues [21] detected BCoV RNA in serum samples from
calves infected with a winter dysentery strain between
day three and eight post inoculation. They used nested
PCR for detection, which is generally a more sensitive
method than RT-qPCR, but also more vulnerable for
contamination [34]. Short viremic period or intake of a
lower virus dose in naturally infected calves could also
explain the negative results in the present study. Inhib-
ition of the RT-qPCR by plasma components was tested
and ruled out. Despite the absence of detectable viremia
in the present study, BCoV RNA was found in mesen-
teric lymph nodes at late stages of the infection. Viral
RNA must have been transferred in low concentrations
in blood or lymph to the draining lymph node, by anti-
gen presenting cells or as free virus particles.
The finding of BCoV RNA in lymph nodes, ileum and
colon six weeks after infection indicates coronavirus
persistence in calves, however, the importance of this
persistence for virus transmission is uncertain. Other
coronaviruses are known to create persistent or chronic
infections in mice and cats [35, 36]. MERS-CoV is
shown to be excreted for more than a month in humans
[37] and human coronavirus 229E creates persistent in-
fections in vitro [38]. Although fecal shedding of BCoV
RNA was detected five weeks post infection in the
present study, the transmission potential at this stage is
most likely negligible, as at three weeks post infection.
BCoV VRC were quantified by RT-qPCR, which does
not give information on the number of infective parti-
cles. The ratio of total to infective particles (T/I) is chal-
lenging to establish for BCoV due to difficulties in
cultivating virus from clinical samples. In the present
study, virus titration showed a T/I ratio of approximately
Fig. 6 HRT-18G cells infected with BCoV from a nasal swab. The
cells were infected with supernatant from a nasal swab taken from
calf E3 six days after exposure to BCoV. The cells are stained with
anti-coronavirus antibodies labelled with fluorescein isothiocynate
and DAPI nuclear counterstain
Table 3 Log10 viral RNA copies of BCoV per gram tissue





22 E4 6.9 6.3 Not done Not done Not done
28 E2 6.7 Negative Not done Not done Not done
35 E3 Negative 5.0 Negative 6.0 5.2
42 E1 6.2 7.4 Negative 7.0 6.0
Tissue samples from lymph nodes, lung, Ileum and Colon were harvested from exposed group calves euthanized at the indicated number of days after exposure
to field group calves. The number of viral RNA copies (VRC) of BCoV was quantified with RT-qPCR and the limit of quantification was 4.2 log10 VRC/g tissue
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5 log10. With this high T/I ratio it is not surprising that
virus isolation was unsuccessful after D13, when the
VRC numbers are decreasing. It also agrees with the
sentinel calves not getting infected D21. In contrast,
roughly 8.8 log10 VRC were detected per nasal swab and
gram feces from the seronegative FG calves that infected
the EG calves. With a T/I ratio of 5 log10, each nasal
swab and gram of feces contained more than 3.8 log10
infective virus particles.
The high T/I ratio and the failure of virus isolation
after D13 could be due to either few infective particles
or low sensitivity of the isolation method. Low levels of
infective particles could be caused either by high pro-
duction of defective particles or by neutralizing effect
of antibodies. Low sensitivity could be caused by sub-
optimal conditions in cell culture compared to in vivo
(particularly for virus from clinical samples not adapted to
cell culture growth), dilution of viral content in the swab,
and freezing and thawing of the material. For feline enteric
coronavirus, the T/I increased from 3–4 log10 during the
first week after infection, to up to 8 log10 28 days post in-
fection [39], the increase possibly caused by the antibody
response.
Few methods are available for studying transmission
potential apart from live animal experiments, although
ethically challenging and resource demanding. Existing
literature is based on experimental studies examining
BCoV shedding for 14 [20, 22, 40] to 21 [19, 41] days.
To the authors’ knowledge, the present study is the first
to study the shedding for as long as six weeks under ex-
perimental conditions. In addition, it is also the first to
study the impact of this shedding using sentinel calves.
Although a low number of calves were used, the results
indicate that calves are not infectious three weeks after
exposure to BCoV. This information is important and
relevant in order to produce scientific based advices on
how to avoid introduction of BCoV into herds. Further
investigation of calves at different stages of disease is
recommended to verify and corroborate these findings.
The effect of stress related to transport on viral shedding
and infectivity should also be considered.
In the present study, the virus that caused winter dys-
entery in adult cattle primarily gave respiratory disease
in calves. Niskanen et al. also found that BCoV derived
from an outbreak of winter dysentery caused mainly re-
spiratory disease in weaned calves [29], supporting that
BCoV is an important cause of respiratory disease in
calves [42, 43] and winter dysentery in adults [17]. The
economic and welfare consequences of BCoV therefore
include the combined effects of neonatal enteritis, re-
spiratory disease in young cattle and winter dysentery in
adults. Also considering the high prevalence worldwide,
BCoV is an important loss-inflicting factor in the cattle
industry.
Conclusions
The current study shows that calves infected with BCoV
are RT-qPCR positive in nasal and fecal specimens for a
longer period than earlier recognized. However, contact
with naïve calves three weeks after exposure did not lead
to infection. A low level of infective particles could be
due to either production of a high level of defective par-
ticles and/or production of neutralizing antibodies. The
study provides highly relevant information when design-
ing biosecurity advice regarding animal trade and coro-
naviral disease in cattle.
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